361 related articles for article (PubMed ID: 22730558)
21. A novel mutation in the PYGM gene in a family with pseudo-dominant transmission of McArdle disease.
Isackson PJ; Tarnopolsky M; Vladutiu GD
Mol Genet Metab; 2005 Jul; 85(3):239-42. PubMed ID: 15979037
[TBL] [Abstract][Full Text] [Related]
22. The effect of muscle glycogen phosphorylase (Pygm) knockdown on zebrafish morphology.
Migocka-Patrzałek M; Lewicka A; Elias M; Daczewska M
Int J Biochem Cell Biol; 2020 Jan; 118():105658. PubMed ID: 31747538
[TBL] [Abstract][Full Text] [Related]
23. Gene symbol: PYGM. Disease: McArdle disease.
Viéitez I; Teijeira S; Miranda S; San Millán B; Navarro C
Hum Genet; 2008 Oct; 124(3):294. PubMed ID: 18846609
[No Abstract] [Full Text] [Related]
24. Two novel mutations in the myophosphorylase gene in a patient with McArdle disease.
Deschauer M; Hertel K; Zierz S
Muscle Nerve; 2003 Jan; 27(1):105-7. PubMed ID: 12508303
[TBL] [Abstract][Full Text] [Related]
25. McArdle disease: what do neurologists need to know?
Lucia A; Nogales-Gadea G; Pérez M; Martín MA; Andreu AL; Arenas J
Nat Clin Pract Neurol; 2008 Oct; 4(10):568-77. PubMed ID: 18833216
[TBL] [Abstract][Full Text] [Related]
26. Sodium valproate increases the brain isoform of glycogen phosphorylase: looking for a compensation mechanism in McArdle disease using a mouse primary skeletal-muscle culture in vitro.
de Luna N; Brull A; Guiu JM; Lucia A; Martin MA; Arenas J; Martí R; Andreu AL; Pinós T
Dis Model Mech; 2015 May; 8(5):467-72. PubMed ID: 25762569
[TBL] [Abstract][Full Text] [Related]
27. McArdle disease: molecular genetic update.
Andreu AL; Nogales-Gadea G; Cassandrini D; Arenas J; Bruno C
Acta Myol; 2007 Jul; 26(1):53-7. PubMed ID: 17915571
[TBL] [Abstract][Full Text] [Related]
28. Muscle glycogenosis and mitochondrial hepatopathy in an infant with mutations in both the myophosphorylase and deoxyguanosine kinase genes.
Mancuso M; Filosto M; Tsujino S; Lamperti C; Shanske S; Coquet M; Desnuelle C; DiMauro S
Arch Neurol; 2003 Oct; 60(10):1445-7. PubMed ID: 14568816
[TBL] [Abstract][Full Text] [Related]
29. High-resolution melting facilitates mutation screening of PYGM in patients with McArdle disease.
Duno M; Quinlivan R; Vissing J; Schwartz M
Ann Hum Genet; 2009 May; 73(Pt 3):292-7. PubMed ID: 19472443
[TBL] [Abstract][Full Text] [Related]
30. Manifesting heterozygotes in McArdle disease: a myth or a reality-role of statins.
Núñez-Manchón J; Ballester-Lopez A; Koehorst E; Linares-Pardo I; Coenen D; Ara I; Rodriguez-Lopez C; Ramos-Fransi A; Martínez-Piñeiro A; Lucente G; Almendrote M; Coll-Cantí J; Pintos-Morell G; Santos-Lozano A; Arenas J; Martín MA; de Castro M; Lucia A; Santalla A; Nogales-Gadea G
J Inherit Metab Dis; 2018 Nov; 41(6):1027-1035. PubMed ID: 29926259
[TBL] [Abstract][Full Text] [Related]
31. Novel human pathological mutations. Gene symbol: PYGM. Disease: McArdle disease.
Viéitez I; Teijeira S; Miranda S; San Millán B; Navarro C
Hum Genet; 2010 Jan; 127(1):114-5. PubMed ID: 20108426
[No Abstract] [Full Text] [Related]
32. Do carriers of PYGM mutations have symptoms of McArdle disease?
Andersen ST; Dunø M; Schwartz M; Vissing J
Neurology; 2006 Aug; 67(4):716-8. PubMed ID: 16924035
[TBL] [Abstract][Full Text] [Related]
33. A novel nonsense mutation (R269X) in the myophosphorylase gene in a patient with McArdle disease.
Deschauer M; Opalka JR; Lindner A; Zierz S
Mol Genet Metab; 2001 Dec; 74(4):489-91. PubMed ID: 11749054
[TBL] [Abstract][Full Text] [Related]
34. Glycogen storage disease type V (Mc Ardle's disease): a report on three cases.
Krishnamoorthy N; Santosh V; Yasha TC; Mahadevan A; Shankar SK; Jethwani D; Taly AB; Bhanu K; Gayathri N
Neurol India; 2011; 59(6):884-6. PubMed ID: 22234204
[TBL] [Abstract][Full Text] [Related]
35. Exercising with blocked muscle glycogenolysis: Adaptation in the McArdle mouse.
Nielsen TL; Pinós T; Brull A; Vissing J; Krag TO
Mol Genet Metab; 2018 Jan; 123(1):21-27. PubMed ID: 29174367
[TBL] [Abstract][Full Text] [Related]
36. Single-centre experience on genotypic and phenotypic features of southern Brazilian patients with McArdle disease.
Lorenzoni PJ; Werneck LC; Kay CSK; Arndt RC; Silvado CES; Scola RH
Acta Neurol Belg; 2020 Apr; 120(2):303-311. PubMed ID: 30415384
[TBL] [Abstract][Full Text] [Related]
37. Six novel mutations in the myophosphorylase gene in patients with McArdle disease and a family with pseudo-dominant inheritance pattern.
Wu Y; Weber JL; Vladutiu GD; Tarnopolsky MA
Mol Genet Metab; 2011 Dec; 104(4):587-91. PubMed ID: 21880526
[TBL] [Abstract][Full Text] [Related]
38. Molecular and clinical study of McArdle's disease in a cohort of 123 European patients. Identification of 20 novel mutations.
Vieitez I; Teijeira S; Fernandez JM; San Millan B; Miranda S; Ortolano S; Louis S; Laforet P; Navarro C
Neuromuscul Disord; 2011 Dec; 21(12):817-23. PubMed ID: 21802952
[TBL] [Abstract][Full Text] [Related]
39. Novel human pathological mutations. Gene symbol: PYGM. Disease: McArdle disease.
Garcia-Consuegra I; Rubio JC; Nogales-Gadea G; Bautista J; Jiménez S; Cabello A; Lucía A; Andreu AL; Arenas J; Martin MA
Hum Genet; 2009 Apr; 125(3):343. PubMed ID: 19320016
[No Abstract] [Full Text] [Related]
40. Novel human pathological mutations. Gene symbol: PYGM. Disease: McArdle disease.
Viéitez I; Teijeira S; Millán BS; Navarro C
Hum Genet; 2009 Apr; 125(3):337. PubMed ID: 19309783
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
